Identification of peptidoglycan-Associated proteins as vaccine candidates for enterococcal infections

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Romero Saavedra, Felipe ^a,b   Laverde, Diana ^a,b   Wobser, Dominique ^a   Michaux, Charlotte ^b,f   Budin Verneuil, Aurélie ^b   Bernay, Benoit ^d   Benachour, Abdellah ^b   Hartke, Axel ^b   Huebner, Johannes ^a,c,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITÉ DE CAEN   (France)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Biology and Innovative Therapeutics for Ovarian Cancers group   (France)

^e German Center for Infection Research   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BINDING PROTEIN; CARBOXYPEPTIDASE; DEXTRO ALANYL DEXTRO ALANINE CARBOXYPEPTIDASE; LYSM PROTEIN; MEMBRANE LIPOPROTEIN; PENICILLIN BINDING PROTEIN 5; PEPTIDOGLYCAN ASSOCIATED PROTEIN; PEPTIDYLPROLYL ISOMERASE; POLYCLONAL ANTIBODY; SCP LIKE EXTRACELLULAR PROTEIN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; CROSS REACTION; ELUTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTRACTION; FEMALE; GENE OVEREXPRESSION; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PH; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEOMICS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; BACTEREMIA; BAGG ALBINO MOUSE; BLOOD; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; IMMUNOLOGY; RABBIT; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CROSS REACTIONS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICE; MICE, INBRED BALB C; PEPTIDOGLYCAN; RABBITS; VACCINATION;

EID: 84943323877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111880     Document Type: Article

References (73)

1. Murray BE (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342: 710-721. doi:10.1056/NEJM200003093421007.
2. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, et al. (2012) The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 17.
3. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, et al. (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34: 1-14. doi:10.1086/668770.
4. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, et al. (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13.
5. Arias C a, Murray BE (2009) Antibiotic-resistant bugs in the 21st century-A clinical super-challenge. N Engl J Med 360: 439-443. doi:10.1056/NEJMp0804651.
6. Top J, Willems R, van der Velden S, Asbroek M, Bonten M (2008) Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J Clin Microbiol 46: 214-219. doi:10.1128/JCM.01351-07.
7. Treitman A, Yarnold P (2005) Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 43: 462-463. doi:10.1128/JCM.43.1.462.
8. Fisher K, Phillips C (2009) The ecology, epidemiology and virulence of Enterococcus. Microbiology 155: 1749-1757. doi:10.1099/mic.0.026385-0.
9. Sava IG, Heikens E, Huebner J (2010) Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 16: 533-540. doi:10.1111/j.1469-0691.2010.03213.x.
10. Repp C, Huebner J (2012) Protective Immune Response. In: Semedo- Lemsaddek T, Barreto-Crespo MT, Tenreiro R, editors. Enterococcus and Safety. Lisbone: Nova Science Publishers, Incorporated. pp. 305-317.
11. Schneewind O, Missiakas DM (2012) Protein secretion and surface display in Gram-positive bacteria. Philos Trans R Soc Lond B Biol Sci 367: 1123-1139. doi:10.1098/rstb.2011.0210.
12. Lindahl G (2005) Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18: 102-127. doi:10.1128/CMR.18.1.102.
13. Ton-That H, Marraffini LA, Schneewind O (2004) Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim Biophys Acta 1694: 269-278. doi:10.1016/j.bbamcr.2004.04.014.
14. Lin J, Huang S, Zhang Q (2002) Outer membrane proteins: key players for bacterial adaptation in host niches. Microbes Infect 4: 325-331. doi:10.1016/S1286-4579(02)01545-9.
15. Janulczyk R, Rasmussen M (2001) Improved Pattern for Genome-Based Screening Identifies Novel Cell Wall-Attached Proteins in Gram-Positive Bacteria. Infect Immun 69: 4019-4026. doi:10.1128/IAI.69.6.4019.
16. Zervosen A, Sauvage E, Frere J-M, Charlier P, Luxen A (2012) Development of new drugs for an old target: the penicillin binding proteins. Molecules 17: 12478-12505. doi:10.3390/molecules171112478.
17. Kumar P, Arora K, Lloyd JR, Lee IY, Nair V, et al. (2012) Meropenem inhibits D, D-carboxypeptidase activity in Mycobacterium tuberculosis. Mol Microbiol 86: 367-381. doi:10.1111/j.1365-2958.2012.08199.x.
18. Olaya-Abril A, Jimenez-Munguia I, Gómez-Gascon L, Obando I, Rodriguez- Ortega MJ (2013) Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults. PLoS One 8: e70365. doi:10.1371/journal.pone.0070365.
19. Assaad U, El-Masri I, Porhomayon J, El-Solh AA (2012) Pneumonia immunization in older adults: review of vaccine effectiveness and strategies. Clin Interv Aging 7: 453-461. doi:10.2147/CIA.S29675.
20. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol 13: 655-692. doi:10.1146/annurev.iy.13.040195.003255.
21. Singh K V, Nallapareddy SR, Sillanpaa J, Murray BE (2010) Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis. PLoS Pathog 6: e1000716. doi:10.1371/journal.ppat.1000716.
22. McCormick JK, Hirt H, Waters CM, Tripp TJ, Dunny GM, et al. (2001) Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis. Infect Immun 69: 3305-3314. doi:10.1128/IAI.69.5.3305-3314.2001.
23. Kropec A, Sava IG, Vonend C, Sakinc T, Grohmann E, et al. (2011) Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections. Microbiology 157: 3429-3434. doi:10.1099/mic.0.053207-0.
24. Burnie J, Carter T, Rigg G, Hodgetts S, Donohoe M, et al. (2002) Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy. FEMS Immunol Med Microbiol 33: 179-189. doi:10.1111/j.1574-695X.2002.tb00589.x.
25. Sava IG, Heikens E, Kropec A, Theilacker C, Willems R, et al. (2010) Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection. J Med Microbiol 59: 1001-1004. doi:10.1099/jmm.0.020578-0.
26. Rodriguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, et al. (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24: 191-197. doi:10.1038/nbt1179.
27. Hempel K, Herbst F-A, Moche M, Hecker M, Becher D (2011) Quantitative proteomic view on secreted, cell surface-associated, and cytoplasmic proteins of the methicillin-resistant human pathogen Staphylococcus aureus under ironlimited conditions. J Proteome Res 10: 1657-1666. doi:10.1021/pr1009838.
28. Giombini E, Orsini M, Carrabino D, Tramontano A (2010) An automatic method for identifying surface proteins in bacteria: SLEP. BMC Bioinformatics 11: 39. doi:10.1186/1471-2105-11-39.
29. Zhou M, Boekhorst J, Francke C, Siezen RJ (2008) LocateP: genome-scale subcellular-location predictor for bacterial proteins. BMC Bioinformatics 9: 173. doi:10.1186/1471-2105-9-173.
30. Barinov A, Loux V, Hammani A, Nicolas P, Langella P, et al. (2009) Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics 9: 61-73. doi:10.1002/pmic.200800195.
31. Cole JN, Ramirez RD, Currie BJ, Stuart J, Djordjevic SP, et al. (2005) Surface Analyses and Immune Reactivities of Major Cell Wall-Associated Proteins of Group A Streptococcus. Infect Immun 75: 3137-3146. doi:10.1128/IAI.73.5.3137.
32. Gatlin CL, Pieper R, Huang S-T, Mongodin E, Gebregeorgis E, et al. (2006) Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 6: 1530-1549. doi:10.1002/pmic.200500253.
33. Benachour A, Morin T, Hébert L, Budin-Verneuil A, Le Jeune A, et al. (2009) Identification of secreted and surface proteins from Enterococcus faecalis. Can J Microbiol 55: 967-974. doi:10.1139/w09-052.
34. Tjalsma H, Lambooy L, Hermans PW, Swinkels DW (2008) Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics 8: 1415-1428. doi:10.1002/pmic.200700550.
35. Leavis HL, Willems RJL, van Wamel WJB, Schuren FH, Caspers MPM, et al. (2007) Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog 3: e7. doi:10.1371/journal.ppat.0030007.
36. Hempel K, Pane-Farre J, Otto A, Sievers S, Hecker M, et al. (2010) Quantitative cell surface proteome profiling for SigB-dependent protein expression in the human pathogen Staphylococcus aureus via biotinylation approach. J Proteome Res 9: 1579-1590. doi:10.1021/pr901143a.
37. Morsczeck C, Prokhorova T, Sigh J, Pfeiffer M, Bille-Nielsen M, et al. (2008) Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect 14: 74-81. doi:10.1111/j.1469- 0691.2007.01878.x.
38. Reffuveille F, Serror P, Chevalier S, Budin-Verneuil A, Ladjouzi R, et al. (2012) The prolipoprotein diacylglyceryl transferase (Lgt) of Enterococcus faecalis contributes to virulence. Microbiology 158: 816-825. doi:10.1099/mic.0.055319-0.
39. Yu C, Chen Y, Lu C, Hwang J (2006) Prediction of Protein Subcellular Localization. Proteins 651: 643-651. doi:10.1002/prot.
40. Chou K-C, Shen H-B (2008) Cell-PLoc: A package of Web servers for predicting subcellular localization of proteins in various organisms. Nat Protoc 3: 153-162. doi:10.1038/nprot.2007.494.
41. Shen H-B, Chou K-C (2009) Gpos-mPLoc: A Top-Down Approach to Improve the Quality of Predicting Subcellular Localization of Gram-Positive Bacterial Proteins. Protein Pept Lett 16: 1478-1484. doi:10.2174/092986609789839322.
42. Shen H-B, Chou K-C (2007) Gpos-PLoc: An ensemble classifier for predicting subcellular localization of Gram-positive bacterial proteins. Protein Eng Des Sel 20: 39-46. doi:10.1093/protein/gzl053.
43. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual, Volume 1. 3rd ed. Cold Spring Harbor, NY: CSHL Press.
44. Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, et al. (1999) Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun 67: 1213-1219.
45. Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB (2000) Prophylactic and Therapeutic Efficacy of Antibodies to a Capsular Polysaccharide Shared among Vancomycin-Sensitive and -Resistant Enterococci. Infect Immun 68: 4631-4636. doi:10.1128/IAI.68.8.4631-4636.2000.
46. Theilacker C, Kaczynski Z, Kropec A, Sava I, Ye L, et al. (2011) Serodiversity of opsonic antibodies against Enterococcus faecalis-glycans of the cell wall revisited. PLoS One 6: e17839. doi:10.1371/journal.pone.0017839.
47. Buist G, Steen A, Kok J, Kuipers OP (2008) LysM, a widely distributed protein motif for binding to (peptido)glycans. Mol Microbiol 68: 838-847. doi:10.1111/j.1365-2958.2008.06211.x.
48. Navarre WW, Schneewind O (1999) Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63: 174-229.
49. Sauvage E, Kerff F, Terrak M, Ayala J a, Charlier P (2008) The penicillinbinding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 234-258. doi:10.1111/j.1574-6976.2008.00105.x.
50. Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, et al. (2002) The 2.4-A° crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. Cell Mol Life Sci 59: 1223-1232. doi:10.1007/s00018-002-8500-0.
51. Zhang X, Paganelli FL, Bierschenk D, Kuipers A, Bonten MJM, et al. (2012) Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium. PLoS Genet 8: e1002804. doi:10.1371/journal.pgen.1002804.
52. Hyyrylainen H-L, Marciniak BC, Dahncke K, Pietiainen M, Courtin P, et al. (2010) Penicillin-binding protein folding is dependent on the PrsA peptidylprolyl cis-trans isomerase in Bacillus subtilis. Mol Microbiol 77: 108-127. doi:10.1111/j.1365-2958.2010.07188.x.
53. Hufnagel M, Hancock LE, Koch S, Theilacker C, Gilmore MS, et al. (2004) Serological and genetic diversity of capsular polysaccharides in Enterococcus faecalis. J Clin Microbiol 42: 2548-2557. doi:10.1128/JCM.42.6.2548-2557.2004.
54. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, et al. (2005) Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309: 148-150. doi:10.1126/science.1109869.
55. Pizza M (2000) Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing. Science (80) 287: 1816-1820. doi:10.1126/science.287.5459.1816.
56. Jeffery CJ (2003) Moonlighting proteins: old proteins learning new tricks. Trends Genet 19: 415-417. doi:10.1016/S0168-9525(03)00167-7.
57. Olaya-Abril A, Jimenez-Munguia I, Gomez-Gascon L, Rodriguez-Ortega MJ (2014) Surfomics: shaving live organisms for a fast proteomic identification of surface proteins. J Proteomics 97: 164-176. doi:10.1016/j.jprot.2013.03.035.
58. Carneiro CRW, Postol E, Nomizo R, Reis LFL, Brentani RR (2004) Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureus. Microbes Infect 6: 604-608. doi:10.1016/j.micinf.2004.02.003.
59. Pancholi V, Fischetti VA (1998) {alpha}-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci. J Biol Chem 273: 14503-14515. doi:10.1074/jbc.273.23.14503.
60. Baums CG, Valentin-Weigand P (2009) Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim Health Res Rev 10: 65-83. doi:10.1017/S146625230999003X.
61. Modun B, Williams P (1999) The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun 67: 1086- 1092.
62. Dallo SF, Kannan TR, Blaylock MW, Baseman JB (2002) Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 46: 1041-1051. doi:10.1046/j.1365-2958.2002.03207.x.
63. Schaumburg J, Diekmann O, Hagendorff P, Bergmann S, Rohde M, et al. (2004) The cell wall subproteome of Listeria monocytogenes. Proteomics 4: 2991-3006. doi:10.1002/pmic.200400928.
64. Zysk G, Bongaerts RJM, ten Thoren E, Bethe G, Hakenbeck R, et al. (2000) Detection of 23 Immunogenic Pneumococcal Proteins Using Convalescent- Phase Serum. Infect Immun 68: 3740-3743. doi:10.1128/IAI.68.6.3740-3743.2000.
65. Vytvytska O, Nagy E, Blüggel M, Meyer HE, Kurzbauer R, et al. (2002) Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2: 580-590. doi:10.1002/1615-9861(200205)2:5, 580::AID-PROT580.3.0.CO;2-G.
66. Gillis TP, Miller RA, Young DB, Khanolkar SR, Buchanan TM (1985) Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect Immun 49: 371-377.
67. Hennequin C, Collignon A, Karjalainen T (2001) Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress. Microb Pathog 31: 255-260. doi:10.1006/mpat.2001.0468.
68. Reffuveille F, Connil N, Sanguinetti M, Posteraro B, Chevalier S, et al. (2012) Involvement of peptidylprolyl cis/trans isomerases in Enterococcus faecalis virulence. Infect Immun 80: 1728-1735. doi:10.1128/IAI.06251-11.
69. Aakra A, Vebø H, Snipen L, Hirt H, Aastveit A, et al. (2005) Transcriptional response of Enterococcus faecalis V583 to erythromycin. Antimicrob Agents Chemother 49: 2246-2259. doi:10.1128/AAC.49.6.2246-2259.2005.
70. Willems RJL, Top J, van Santen M, Robinson DA, Coque TM, et al. (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11: 821-828. doi:10.3201/eid1106.041204.
71. Hufnagel M, Koch S, Kropec A, Huebner J (2003) Opsonophagocytic assay as a potentially useful tool for assessing safety of enterococcal preparations. Int J Food Microbiol 88: 263-267. doi:10.1016/S0168-1605(03)00189-2.
72. Van den Bogaard A (1997) High prevalence of colonization with vancomycinand pristinamycin- resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 40: 454-456. doi:10.1093/jac/40.3.454.
73. Maekawa S, Yoshioka M, Kumamoto Y (1992) Proposal of a New Scheme for the Serological Typing of Enterococcus faecalis Strains. Microbiol Immunol 36: 671-681. doi:10.1111/j.1348-0421.1992.tb02070.x.